Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367390 · ClinicalTrials.gov registry record · Phase 1
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
A Phase 1 study of Type1 Diabetes Mellitus, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03367390 is a Phase 1 study of Type1 Diabetes Mellitus that has completed, run by Eli Lilly and Company. The registered enrollment target is 30 participants, below the 754-participant average among 6 other Type1 Diabetes Mellitus trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03367390, a Phase 1 study of Type1 Diabetes Mellitus, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system and to test whether the AID System functions as it was designed to. This study will last approximately 12-18 days, not including screening. Screening is required within 28 days prior to the start of the study.
Conditions Studied
Interventions
- DEVICE AID System
- DRUG Insulin Lispro
Study Locations (1)
Washington
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2018-02-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367390
The ClinicalTrials.gov registry entry for NCT03367390 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 754-participant average among 6 other Type1 Diabetes Mellitus trials with a reported enrollment target (96% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type1 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which AID System is the first listed.
NCT03367390 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT03367390 about?
NCT03367390 is a clinical study titled "A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)". The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system and to test whether the AID System functions as it was designed to. This study will l...
What is the current status of trial NCT03367390?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2017-11-08. Estimated completion is 2018-02-09.
What conditions does trial NCT03367390 study?
This clinical trial studies the following conditions: Type1 Diabetes Mellitus.
What interventions are being tested in trial NCT03367390?
The interventions under investigation include: AID System (DEVICE), Insulin Lispro (DRUG).
Who is sponsoring clinical trial NCT03367390?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03367390 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
RECRUITING
-
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
ACTIVE NOT RECRUITING
-
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
COMPLETED · Phase 2
-
The Insulin-Only Bionic Pancreas Bridging Study
COMPLETED · Phase 2
-
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.